At last week’s American Society of Nephrology Kidney Week 2017, held in New Orleans, Louisiana, researchers suggested that insomnia can increase one’s risk of kidney failure and early death. The researchers at the University of Tennessee Health Science Center found that in their study of United States veterans, chronic insomnia greatly increased the risk of kidney function decline, kidney failure, and early mortality. The researchers proposed managing chronic insomnia in order to reduce these risks.
Patients are diagnosed with insomnia every day as they visit their healthcare providers at their primary medical care centers or urgent care clinics. The Centers for Disease Control and Prevention (CDC), reports that 35.2% of U.S. adults have been diagnosed with insomnia. Insomnia has been linked to other physical and mental conditions such as depression, attention deficit hyperactivity disorder (ADHD), and Alzheimer’s.
In this research study, it was discovered that “chronic insomnia was tied to 1.4 times higher risk of mortality for any cause, as well as 1.5 times higher risk of kidney decline, and an even steeper increase in the risk of kidney failure: 2.4 times.” Discussing ways to manage sleeplessness with a medical professional at any primary medical care center or urgent care clinic, is essential for overall health. Chronic kidney disease (CKD) affects 14% of the U.S. population. The risk factors for developing CKD include, obesity, smoking, diabetes, and hypertension. Managing one’s sleep as well as these conditions can lessen the risk of kidney failure and the need for more drastic treatment options such as dialysis and kidney transplants.
The researchers do concede to the fact that more in-depth studies and clinical trials are required to fully confirm these preliminary findings. The takeaway is precautionary and urges those who suffer from chronic insomnia to take it seriously. As with any health concern, consulting one’s healthcare provider at any primary medical care center or urgent care clinic is essential.